| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 12/11/2008 | WO1999027105A9 Chlamydia pneumoniae genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection |
| 12/11/2008 | US20080307549 Polysaccharide Synthases |
| 12/11/2008 | US20080307547 Stimulating root growth via introducing cytokinin oxidase protein sequences; point mutations |
| 12/11/2008 | US20080307546 Cyclin-dependent kinase inhibitors and uses thereof |
| 12/11/2008 | US20080307536 Voltage-Gated, Ph-Sensitive Anion Channel And Its Novel Splice Variant Involved In Taste Sensation |
| 12/11/2008 | US20080306247 Antibody-containing solution formulations |
| 12/11/2008 | US20080306246 Process for Attaching Effector Molecules to Proteins |
| 12/11/2008 | US20080306004 Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides |
| 12/11/2008 | US20080305998 appetite stimulants, antiobesity drugs, prolactin production inhibitors; drug screening; G-protein coupled (GPR) |
| 12/11/2008 | US20080305996 Novel tumor necrosis factor receptor homologs and nucleic acids encoding the same |
| 12/11/2008 | US20080305988 V-Like Domain Binding Molecules |
| 12/11/2008 | US20080305550 Targets for Detection of Ischemia |
| 12/11/2008 | US20080305543 RNA interference pathway genes as tools for targeted genetic interference |
| 12/11/2008 | US20080305525 production system for a recombinant glycoprotein having therapeutic value in humans using a methylotrophic, thermotolerant yeast; host system for mass production of recombinant hepatitis vaccines |
| 12/11/2008 | US20080305516 Method of Producing Antibodies |
| 12/11/2008 | US20080305502 Method of Screening Baff Suppressor or Inhibitor |
| 12/11/2008 | US20080305499 Anti-Synoviolin Antibody |
| 12/11/2008 | US20080305497 Polymeric carriers for immunohistochemistry and in situ hybridization |
| 12/11/2008 | US20080305491 Mcm6 and mcm7 monoclonal antibodies and methods for their use in the detection of cervical disease |
| 12/11/2008 | US20080305490 Amplification of human mdm2 gene in human tumors |
| 12/11/2008 | US20080305123 Functional Epitopes of Streptococcus Pneumoniae PsaA Antigen and Uses Thereof |
| 12/11/2008 | US20080305121 Agents for Regulating the Activity of Interferon-Producing Cells |
| 12/11/2008 | US20080305118 Treatment Of Type 1 Diabetes With Inhibitors Of Macrophage Migration Inhibitory Factor |
| 12/11/2008 | US20080305117 Kir-Binding Agents and Methods of Use Thereof |
| 12/11/2008 | US20080305116 Anti-Cd154 Antibodies |
| 12/11/2008 | US20080305114 Human antibodies that bind human il-12 and methods for producing |
| 12/11/2008 | US20080305111 Anti-C35 antibodies for treating cancer |
| 12/11/2008 | US20080305109 Method of passive immunization |
| 12/11/2008 | US20080305108 Peptides of Il1 Beta and Tnf Alpha and Method Treatment |
| 12/11/2008 | US20080305106 Novel Gene Disruptions, Composition and Methods Relating Thereto |
| 12/11/2008 | US20080305105 Bispecific antibodies |
| 12/11/2008 | US20080305104 Cytotoxicity mediation of cells evidencing surface expression of TROP-2 |
| 12/11/2008 | US20080305102 Therapeutic Agent for Cancer Comprising Substance Capable of Inhibiting Expression or Function of Synoviolin as Active Ingredient and Screening Method for the Therapeutic Agent for Cancer |
| 12/11/2008 | US20080305101 Methods and Compositions Related to Clot Binding Compounds |
| 12/11/2008 | US20080305098 Recombinant Polypeptides and Methods for Detecting and/or Quantifying Autoantibodies Against Tsh Receptor |
| 12/11/2008 | US20080305092 Methods of treating autoimmune disease via CTLA-4IG |
| 12/11/2008 | US20080305078 Soluble Il-17Rc Variant and Uses Thereof |
| 12/11/2008 | US20080305074 Stem cell factor |
| 12/11/2008 | US20080305044 Engineered Antibodies and Immunoconjugates |
| 12/11/2008 | US20080305038 Transport of Nano-and Macromolecular Structures Into Cytoplasm and Nucleus of Cells |
| 12/11/2008 | CA2724432A1 Compositions and methods for binding lysophosphatidic acid |
| 12/11/2008 | CA2693053A1 Methods and compositions for inhibiting cd32b expressing cells |
| 12/11/2008 | CA2689938A1 Compositions and methods for treating pancreatic tumors |
| 12/11/2008 | CA2689570A1 Induction of tolerogenic phenotype in mature dendritic cells |
| 12/11/2008 | CA2689556A1 Expression of soluble antibody fragment by truncation of ch1 domain |
| 12/11/2008 | CA2689302A1 Clostridial toxin netb |
| 12/11/2008 | CA2689272A1 Novel plant virus designated tomato marchitez virus |
| 12/11/2008 | CA2688678A1 Fhl1 mutations associated with novel x-linked muscular myopathies |
| 12/11/2008 | CA2688490A1 Immunoglobulin constant region fc receptor binding agents |
| 12/11/2008 | CA2688489A1 Inhibition of hiv-1 infection by potent metallocene conjugated peptide through conformational entrapment of envelope gp120 |
| 12/11/2008 | CA2688456A1 Polypeptides, antibody variable domains & antagonists |
| 12/11/2008 | CA2688447A1 Polypeptides, antibody variable domains & antagonists |
| 12/11/2008 | CA2688434A1 Polypeptides, antibody variable domains and antagonists |
| 12/11/2008 | CA2688433A1 Methods for selecting protease resistant polypeptides |
| 12/11/2008 | CA2687866A1 Anti-notch1 nrr antibodies and methods using same |
| 12/11/2008 | CA2687819A1 Composition of a first non-labeled monoclonal antibody binding to a tumor antigen and a non-cross reactive second monoclonal antibody labeled with a nir fluorescence label |
| 12/11/2008 | CA2687414A1 Humanized antibodies to a.beta. (20-42) globulomer and uses thereof |
| 12/11/2008 | CA2687411A1 Humanized antibodies which bind to a.beta. (1-42) globulomer and uses thereof |
| 12/11/2008 | CA2687368A1 Vaccine for the prevention of breast cancer relapse |
| 12/11/2008 | CA2685594A1 Cancer related isoforms of components of transcription factor complexes as biomarkers and drug targets |
| 12/11/2008 | CA2683823A1 Polypeptides, antibody variable domains & antagonists |
| 12/11/2008 | CA2683801A1 Polypeptides, antibody variable domains and antagonists |
| 12/11/2008 | CA2683791A1 Polypeptides, antibody variable domains & antagonists |
| 12/10/2008 | EP2000802A1 Novel platelet activation marker and method for determination thereof |
| 12/10/2008 | EP2000545A1 Compositions and methods for the diagnosis and treatment of tumor |
| 12/10/2008 | EP2000543A2 Method for the molecular diagnosis of prostate cancer and kit for implementing same |
| 12/10/2008 | EP2000541A1 Humanized anti-cd20 monoclonal antibody |
| 12/10/2008 | EP2000537A2 Polynucleotides and their use for detecting resistance to streptogramin A or to streptogramin B and related compounds |
| 12/10/2008 | EP2000535A1 Circovirus sequences associated with porcine wasting disease (PWD) |
| 12/10/2008 | EP2000532A1 Methods of measuring human cytochrome P450 (CYP2C8/9) |
| 12/10/2008 | EP2000482A1 Compositions and methods for the diagnosis and treatment of tumor |
| 12/10/2008 | EP2000481A1 High affinity anti-human IgE antibodies |
| 12/10/2008 | EP2000479A1 Genetic Sequences and Proteins Related to Alzheimer's Disease, and Uses Therefor |
| 12/10/2008 | EP2000149A1 Chimeric anti-CD20 antibody |
| 12/10/2008 | EP2000148A1 Compositions and methods for the diagnosis and treatment of prostate cancer |
| 12/10/2008 | EP1999474A1 Method for the detection and/or enrichment of analyte proteins and/or analyte peptides from a complex protein mixture |
| 12/10/2008 | EP1999471A2 In vivo induced genes of mycobacterium tuberculosis |
| 12/10/2008 | EP1999470A2 Identification and engineering of antibodies with variant heavy chains and methods of using same |
| 12/10/2008 | EP1999154A2 Engineered heterodimeric protein domains |
| 12/10/2008 | EP1999153A1 Agonist antibodies against tshr |
| 12/10/2008 | EP1999152A1 Binding member for gm-csf receptor |
| 12/10/2008 | EP1999151A2 Diagnostics and treatments for tumors |
| 12/10/2008 | EP1999150A1 New protein isoforms and uses thereof |
| 12/10/2008 | EP1999148A2 Humanized anti-cd22 antibodies and their use in treatment of oncology, transplantation and autoimmune disease |
| 12/10/2008 | EP1999147A1 Medical delivery device for therapeutic proteins based on single domain antibodies |
| 12/10/2008 | EP1998807A2 Methods for humanizing antibodies and humanized antibodies made thereby |
| 12/10/2008 | EP1998806A1 Anti-igf-1r human monoclonal antibody formulation |
| 12/10/2008 | EP1998805A1 Tumor therapy with an antibody for vascular endothelial groeth factor and an antibody for human epithelial growth factor receptor type 2 |
| 12/10/2008 | EP1998799A2 Humanized anti-cd22 antibodies and their use in treatment of oncology, transplantation and autoimmune disease |
| 12/10/2008 | EP1718977B1 Protein phosphorylation in t-cell receptor signaling pathways |
| 12/10/2008 | EP1718976B1 Protein phosphorylation in anaplastic large cell lymphoma |
| 12/10/2008 | EP1670820B1 Antigens for an east coast fever vaccine |
| 12/10/2008 | EP1578254A4 Diagnostic method for diseases by screening for hepcidin in human or animal tissues, blood or body fluids and therapeutic uses therefor |
| 12/10/2008 | EP1483295B1 Rs7 antibodies |
| 12/10/2008 | EP1274450B1 Medical uses of agonsist and antagonists of IL-174 |
| 12/10/2008 | EP1220915B1 Splice variant of head trauma induced cytoplasmatic calcium binding protein |
| 12/10/2008 | EP1220913B1 G protein-coupled receptor up-regulated in prostate cancer and uses thereof |
| 12/10/2008 | EP1218525B1 Utrophin gene promoter |
| 12/10/2008 | EP1212361B1 Preparation of highly pure non-toxic toxin fragments |
| 12/10/2008 | EP1163342B1 Chlamydia antigens and corresponding dna fragments and uses thereof |